Govt Looking into Securing Part of J&J's Covid Vaccine for Indian Market: Sources
3 years, 6 months ago

Govt Looking into Securing Part of J&J's Covid Vaccine for Indian Market: Sources

News 18  

Johnson and Johnson's COVID-19 vaccine to be manufactured in India by Biological E cannot be directly channelled to the domestic market and will have to be handed over entirely to the US pharma giant as agreed by the firms but the government is looking at the possibility of securing a part of this production, sources said. Hyderabad-based Biological E has, however, proposed to manufacture about 30 crore doses of its indigenous vaccine exclusively for the Indian market by December and has sought "funding support" from the government. The sources privy to the discussions said another US pharma company, Moderna, does not have surplus jabs to share in 2021, and is expected to launch a single-dose COVID-19 vaccine in India next year. For its indigenously developed vaccine, Biological E has sought funding support from the government for at-risk manufacturing, essentially for the import of adjuvant which is in "high demand" in the international market.

India Market Indian Market Biological Vaccine Sources Biological E  india  vaccine  securing  jjs  looking  biological  funding  ministry  indian  jj  vaccines  sources  govt  pharma  covid  market

History of this topic

With State prod, India can be world leader in vaccines
10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 6 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
1 year, 11 months ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
1 year, 11 months ago

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses

Live Mint  

The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine doses ready to dispatch as and when orders are received, according to news agency PTI. Currently, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

A PLI-type scheme for 'atmanirbhar' vaccine industry
2 years ago

A PLI-type scheme for 'atmanirbhar' vaccine industry

Live Mint  

The government will likely unveil a ₹2,500 crore financial assistance programme to boost domestic production of vaccine raw materials to enhance self-reliance amid a resurgence of covid cases worldwide, two officials familiar with the development said. Cement investors see Q3 with mixed feelings While India is a global leader in vaccine production, it imports key raw materials needed for manufacturing. …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

Biological E. Limited to invest Rs 1,800 cr in Hyd
2 years, 5 months ago

Biological E. Limited to invest Rs 1,800 cr in Hyd

Deccan Chronicle  

Hyderabad: Biological E. Limited on Thursday announced an investment of Rs 1,801 crore in the city, which would generate 2,518 jobs at its three facilities in Genome Valley, as part of an expansion plan that would cement Hyderabad’s position as the ‘vaccine capital of the world.’ The expansion is primarily targeted to ramp up the manufacturing of vaccines and generic …

Biological E. to invest ₹1,800 crore in Hyderabad’s Genome Valley
2 years, 5 months ago

Biological E. to invest ₹1,800 crore in Hyderabad’s Genome Valley

The Hindu  

Vaccine maker Biological E. will be investing ₹1,800 crore on expansion projects at three of its facilities in Genome Valley, Hyderabad. The investment from Biological E to enhance capacity by 5 billion doses would thus increase the cumulative manufacturing capacity of Hyderabad to about 14 billion doses, further consolidating the city’s leadership in vaccines, the Minister’s office said. The announcement …

Biological E Slashes Price of Corbevax Covid-19 Vaccine to Rs 250 per Dose. Check Details
2 years, 7 months ago

Biological E Slashes Price of Corbevax Covid-19 Vaccine to Rs 250 per Dose. Check Details

News 18  

Biological E on Monday announced reducing the price of each dose its Covid-19 vaccine Corbevax to Rs 250 from Rs 840 at private vaccination centres. In March this year when the inoculation of children in the age group of 12 to 14 years against COVID-19 commenced in the country, Corbevax vaccine was used and its price was fixed at Rs …

A year on, Quad initiative for 1 billion India-made vaccines runs into rough weather
2 years, 7 months ago

A year on, Quad initiative for 1 billion India-made vaccines runs into rough weather

The Hindu  

More than a year after the first Quad summit where the leaders of the U.S., India, Japan and Australia launched an ambitious initiative to produce one billion doses of COVID-19 vaccines for distribution in the Indo-Pacific region, the project is floundering, and officials concede that it is unlikely to meet its target by 2022-end for a number of reasons. While …

Biological E. to receive mRNA vaccine tech from WHO
2 years, 8 months ago

Biological E. to receive mRNA vaccine tech from WHO

The Hindu  

Vaccine maker Biological E. has been selected to receive mRNA technology from the World Health Organization technology transfer hub. After examining a number of proposals from India, the WHO's Advisory Committee on Vaccine Product Development has selected Biological E. as a recipient, the Hyderabad–based firm said on Monday. The company has been investing in mRNA technologies since last year and …

Corbevax safe for kids, offers high antibody levels, says Biological E CEO | EXCLUSIVE
2 years, 9 months ago

Corbevax safe for kids, offers high antibody levels, says Biological E CEO | EXCLUSIVE

India Today  

India's third homegrown Covid-19 vaccine, Corbevax, is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines, said Mahima Datla, managing director of Biological E. Limited on Wednesday. THE CORBEVAX CONTROVERSY Asked how effective the vaccine will be against Omicron, the latest strain to emerge which drove the third wave in, Datla said it was a …

Inside Story of How India Got Its Own Covid Vaccine, Did Not Succumb to Bullying by Foreign Firms
2 years, 9 months ago

Inside Story of How India Got Its Own Covid Vaccine, Did Not Succumb to Bullying by Foreign Firms

News 18  

Speaking of vaccine development, never before has India incubated companies by engaging in proactive risk financing on a scale as enormous as this. NEGVAC’s vaccination strategy was based on two components: the information coming in simultaneously from the manufacturers that vaccine availability would be limited in the first six months due to restrictions in their capacities. At the same time, …

Biological E may soon be available in India's vaccination programme
2 years, 10 months ago

Biological E may soon be available in India's vaccination programme

India Today  

After much delay, the Central government has placed a purchase order with Biological E for five crore doses of Covid vaccine Corbevax. The beneficiaries of the vaccine could likely be between the ages of 12-15 years, although the government has not yet decided to approve the vaccine for those less than 15 years of age. Biological E is also conducting …

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield
2 years, 11 months ago

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield

Firstpost  

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country. New Delhi: Serum Institute of India CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market authorisation of Covishield, stating supplies …

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines
2 years, 11 months ago

Maximising the boost: The Hindu Editorial on mixing COVID-19 vaccines

The Hindu  

Heralding a new frontier in India’s vaccination programme, the apex drug regulator has approved two more vaccines under emergency use authorisation, and an antiviral drug. Despite three vaccines being available, India has overwhelmingly been reliant on Covishield and that is a matter of concern as a new chapter in the vaccination programme unfolds. The new directives say that “precaution doses”, …

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022
2 years, 11 months ago

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022

News 18  

Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday. “Biological E. Limited plans to complete production at a …

Corbevax Samples Cleared by Kasauli Lab, Paving Way for Stockpiling, Vaccine May Hit Market in December
3 years, 1 month ago

Corbevax Samples Cleared by Kasauli Lab, Paving Way for Stockpiling, Vaccine May Hit Market in December

News 18  

A batch of Hyderabad-based pharmaceutical firm Biological E’s Covid vaccine Corbevax has been cleared by the country’s apex testing laboratory in Himachal Pradesh, paving the way for the manufacturer to start stockpiling, News18.com has learnt. The Central Drugs Laboratory in Kasauli on Tuesday cleared the first lot of Corbevax vaccine, which was sent for testing before Biological E can kickstart …

Covid-19: J&J's Hyderabad-made Jabs Get CDL Nod, Over 1 Cr Doses Ready for Export
3 years, 1 month ago

Covid-19: J&J's Hyderabad-made Jabs Get CDL Nod, Over 1 Cr Doses Ready for Export

News 18  

American pharma giant Johnson & Johnson’s Covid-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are ready for export, News18.com learnt. “Once the Drug Controller General of India approves the report sent by CDL and the request filed by the company, the batches can be exported.” The move is in line with Prime Minister Narendra Modi’s announcement at the …

Month On, Johnson & Johnson’s Covid Vaccines Stuck at Kasauli Lab Over Pending Data from Indian Maker
3 years, 2 months ago

Month On, Johnson & Johnson’s Covid Vaccines Stuck at Kasauli Lab Over Pending Data from Indian Maker

News 18  

American pharma giant Johnson & Johnson’s Covid-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are stuck at the country’s apex vaccine testing laboratory in Himachal Pradesh due to pending data, News18.com has learnt. The batch of around 35 lakh vaccine doses, which arrived at the Central Drugs Laboratory in Kasauli over a month ago, are lying at the …

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax
3 years, 2 months ago

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax

Live Mint  

Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin. The company, meanwhile, has put in an application seeking the nod of the Drugs Controller General of India to conduct the …

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official
3 years, 2 months ago

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official

News 18  

The World Health Organisation is deeply concerned that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognised in all countries, an official said on Thursday. Addressing a press briefing, Dr Bruce Aylward, Senior Advisor to WHO Director General Dr Tedros Adhanom Ghebreyesus, said the organisation …

WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries
3 years, 2 months ago

WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries

India TV News  

The World Health Organisation is “deeply concerned” that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognized in all countries, an official said on Thursday. Addressing a press briefing, Dr. Bruce Aylward, Senior Advisor to WHO Director-General Dr. Tedros Adhanom Ghebreyesus, said the organization again …

India may try to find 'middle ground' for usage and export of J&J single-shot jab
3 years, 2 months ago

India may try to find 'middle ground' for usage and export of J&J single-shot jab

Firstpost  

A strategy needs to be put in place where India may take a share of the monthly production of J&J’s vaccine for domestic use, said a senior government official privy to developments on this front The Indian government may initiate a fresh round of talks with Johnson & Johnson to find a middle ground on domestic usage and export of …

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month
3 years, 3 months ago

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month

News 18  

US Pharma giant Johnson & Johnson’s single shot vaccine manufactured by Hyderabad-based Biological E is likely to be rolled out by October, News18.com has learnt. The vaccine batches are expected to go for the final testing at the apex laboratories — Central Drugs Laboratory, Kasauli and National Centre for Cell Science, Pune — by next week. “The vaccine is likely …

Biological E.’s COVID-19 vaccine approved for advanced trials on children
3 years, 3 months ago

Biological E.’s COVID-19 vaccine approved for advanced trials on children

The Hindu  

Hyderabad-based pharmaceutical company Biological E. Limited has been approved by the Drugs Controller General of India to conduct further trials of its vaccine Corbevax on children and adolescents. Health Ministry officials said in June that the Centre had reserved 30 crore doses of the vaccine for inclusion into India’s vaccination drive. These approvals encourage our organisation to move forward and …

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials
3 years, 3 months ago

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials

Hindustan Times  

The Drugs Controller General of India has given approval to Biological E for two clinical trials of its Covid-19 vaccine candidate Corbevax, the ministry of science and technology announced Friday. The Hyderabad-based pharmaceutical company received approval for Phase 3 comparator safety and immunogenicity trial in adults after a review of Phase 1 and 2 clinical trials data by a subject …

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa
3 years, 3 months ago

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa

Live Mint  

The European Union will return to Africa millions of doses of Johnson & Johnson’s Covid-19 vaccine that it received from a plant in South Africa, following criticism by health activists that the bloc was taking away shots from a continent that has the lowest immunization rate in the world. Strive Masiyiwa, who heads the African Union’s Vaccine Acquisition Task Team, …

Biological E’s Corbevax may be launched in October: Niti Aayog’s VK Paul
3 years, 3 months ago

Biological E’s Corbevax may be launched in October: Niti Aayog’s VK Paul

Hindustan Times  

Hyderabad-based pharmaceutical company Biological E may launch its vaccine, ‘Corbevax’, against the coronavirus disease in October with phase three trial underway. In June, the Union health ministry had said Biological E would supply 30 crore doses of Corbevax to India by December. On Wednesday, the Drug Controller General of India gave permission to Biological E to conduct phase 2/3 clinical …

DGCI Gives Nod for Phase 2/3 Trials of Biological E's Covid Vaccine for Children
3 years, 3 months ago

DGCI Gives Nod for Phase 2/3 Trials of Biological E's Covid Vaccine for Children

News 18  

The Drugs Controller General of India on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its ‘Made in India’ COVID-19 vaccine on children aged between 5 and 18 years with certain conditions, sources said. Meanwhile, the data of phase 2/3 clinical trials of Bharat Biotech’s Covaxin in the age group 2 to 18 …

Johnson and Johnson seeks nod for vaccine trials on 12-17 age group
3 years, 4 months ago

Johnson and Johnson seeks nod for vaccine trials on 12-17 age group

The Hindu  

U.S. pharma major Johnson & Johnson has applied for permission to conduct clinical trials of its single-shot COVID-19 vaccine on adolescents aged 12-17 years in India. J&J India spokesperson in a statement said: “We are committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children. On August 17, 2021, we submitted an application …

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents
3 years, 4 months ago

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents

News 18  

Johnson & Johnson on Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years. “On August 17, 2021, we submitted an application to the Central Drugs Standard Control Organisation to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged …

South African activists slam J&J for exporting vaccines
3 years, 4 months ago

South African activists slam J&J for exporting vaccines

Associated Press  

JOHANNESBURG — Health activists in Africa have slammed Johnson & Johnson for exporting vaccines produced in South Africa to countries in Europe, which have already immunized large numbers of their people and have even donated vaccines to more needy countries. The South African activists on Tuesday called for a full disclosure of the South African government’s contracts with Johnson & …

Covid Vaccine Tracker: J&J Doses Expected to Arrive India in Nov-Dec, Zydus Cadila Next
3 years, 4 months ago

Covid Vaccine Tracker: J&J Doses Expected to Arrive India in Nov-Dec, Zydus Cadila Next

News 18  

India is expected to get first doses of the single-shot vaccine of Johnson & Johnson in November or December this year, a top government source said, after the Centre had last week granted Emergency Use Authorization to the foreign Covid-19 vaccine manufacturer. The next coronavirus vaccine that the government is expecting to arrive after Covishield, Covaxin and Sputnik is Zydus …

J&J Single-dose COVID Vaccine Can Improve Coverage in Tough Terrains, Tackle Inequity
3 years, 4 months ago

J&J Single-dose COVID Vaccine Can Improve Coverage in Tough Terrains, Tackle Inequity

News 18  

Johnson and Johnson or Janssen Pharmaceutica NV’s single-dose COVID-19 vaccine has become the fifth vaccine to receive an emergency use license in India on August 7, 2021. However, as with other viral-vectored vaccines, J&J vaccine has been found to be associated with increased risk of a rare adverse event called thrombosis with thrombocytopenia syndrome. How India Can Optimize Benefits of …

How Goes India’s Covid Vaccine Production? Here’s a Look at the Numbers
3 years, 4 months ago

How Goes India’s Covid Vaccine Production? Here’s a Look at the Numbers

News 18  

With Johnson and Johnson‘s single-dose Covid-19 vaccine getting approval for emergency use, India now has five vaccines to offer to its citizens. Before Johnson & Johnson, India’s drug regulator DCGI had over a month ago granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country. As India gets another vaccine added …

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population
3 years, 4 months ago

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population

Firstpost  

J&J earlier had sought approval to conduct phase-3 clinical trial of its vaccine on approximately 600 participants in two age groups—those aged 18 and below 60 years and those aged 60 years and above—to evaluate the safety, reactogenicity and immunogenicity of the jab in healthy Indian adults. Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in …

Johnson and Johnson’s single-dose COVID-19 vaccine approved for emergency use in India
3 years, 4 months ago

Johnson and Johnson’s single-dose COVID-19 vaccine approved for emergency use in India

The Hindu  

Johnson and Johnson’s single-dose COVID-19 vaccine was on Saturday given approval for Emergency Use Authorisation in India, making it the 5th COVID vaccine to get the clearance in the country. It further said the Central Drugs Standard Control Organisation had granted permission to conduct the phase I clinical trial of intranasal adenoviral vector COVID-19 vaccine to Bharat Biotech International Limited, …

Johnson & Johnson Applies for Emergency Approval of Its Single-dose Covid Vaccine in India
3 years, 4 months ago

Johnson & Johnson Applies for Emergency Approval of Its Single-dose Covid Vaccine in India

News 18  

Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization of its single-dose COVID-19 vaccine in India. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021 Johnson & Johnson Pvt …

Johnson & Johnson applies for approval of its single-dose Covid-19 vaccine in India
3 years, 4 months ago

Johnson & Johnson applies for approval of its single-dose Covid-19 vaccine in India

India TV News  

Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization of its single-dose COVID-19 vaccine in India. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021 Johnson & Johnson Pvt …

Johnson & Johnson applies for approval of its single-dose Covid vaccine in India
3 years, 4 months ago

Johnson & Johnson applies for approval of its single-dose Covid vaccine in India

Hindustan Times  

Johnson & Johnson, the 134-year-old American pharma conglomerate, has now applied to the Central Drug Standard Control Organisation of India seeking emergency use approval of its single-shot vaccine. Johnson & Johnson has approached the Central Drug Standard Control Organisation for Emergency Use Authorization for the single-dose Covid-19 vaccine "This is an important milestone that paves the way to bringing our …

Four more Indian pharma firms expected to begin COVID vaccine production by Oct-Nov, says Union health minister
3 years, 4 months ago

Four more Indian pharma firms expected to begin COVID vaccine production by Oct-Nov, says Union health minister

Firstpost  

During the Question Hour in the Rajya Sabha, Mansukh Mandaviya said India has administered 47 crore doses of vaccine so far New Delhi: Union Health Minister Mansukh Mandaviya on Tuesday said in Parliament that four more Indian pharma firms are expected to start anti-coronavirus vaccine production by October-November that will accelerate the inoculation drive. During the Question Hour in the …

J&J Says Still in Talks With India On Vaccine; All You Need to Know About Janssen
3 years, 4 months ago

J&J Says Still in Talks With India On Vaccine; All You Need to Know About Janssen

News 18  

US-based pharmaceutical company Johnson & Johnson said on Monday it was still in talks with the Indian government over its COVID-19 vaccine after the country’s drug regulator announced the company had pulled its proposal seeking an accelerated approval for local trials. “We look forward to ongoing discussions with the Government of India and will continue to explore how to accelerate …

India procured over 100 crore vaccines between Jan and July 16
3 years, 4 months ago

India procured over 100 crore vaccines between Jan and July 16

India Today  

The government has procured a total of 100.6 crore doses from January, 2021 till July 16, 2021, said Union MoS for Ministry of Health and Family Welfare, Dr. Bharati Pravin Pawar, in Rajya Sabha. Dr. Bharati Pravin Pawar was replying to a question by Congress MP Kapil Sibal on the timeline of orders placed for Covid-19 vaccines by the Centre …

Biological E’s Covid Vaccine 'Corbevax' Likely To be Launched By September End
3 years, 4 months ago

Biological E’s Covid Vaccine 'Corbevax' Likely To be Launched By September End

ABP News  

Hyderabad: Pharmaceutical company Biological E is expected to launch its Covid-19 vaccine 'Corbevax' by September end in the country. The report claimed that the government has already booked Biological E's COVID-19 vaccine Corbevax which is currently in advance phase 3 clinical trials for 'at-risk manufacturing' of the COVID-19 vaccine. Union Minister of State for Health, Dr Bharati Pravin Pawar recentky …

Government funding work on four new COVID-19 vaccine candidates
3 years, 5 months ago

Government funding work on four new COVID-19 vaccine candidates

The Hindu  

The Centre is funding the development of four vaccines, which are currently in various stages of human trials. The government has also funded clinical trial sites, animal challenge facilities and immunoassay laboratories, all of which were collectively allotted a budget of ₹900 crore for 12 months, the Minister said. The four vaccines, being funded under Mission Covid Suraksha, were the …

Zydus Cadila has applied for approval, Bio-E's Covid vaccine to enter market by October: Health Minister
3 years, 5 months ago

Zydus Cadila has applied for approval, Bio-E's Covid vaccine to enter market by October: Health Minister

India Today  

Zydus Cadila has applied for Emergency Use Authorisation for its Covid-19 vaccine, Union Health Minister Mansukh Mandaviya told Rajya Sabha on Tuesday. In his first speech in the Rajya Sabha as Union Health Minister, Mansukh Mandaviya also said that there is hope that vaccinations for children will begin soon. We are procuring 11-12 crore doses of AstraZeneca's Covishield from the …

Actively Pursuing Enhancement of Vaccine Availability Through Imports: Govt
3 years, 5 months ago

Actively Pursuing Enhancement of Vaccine Availability Through Imports: Govt

News 18  

The government on Thursday said it is “actively pursuing” the enhancement of Covid vaccine availability through imports and reiterated that its current focus is on purposing domestic production towards its vaccination programme. At an online media briefing, Ministry of External Affairs Spokesperson Arindam Bagchi said India hopes that individual countries would increasingly recognise made-in-India vaccines. “Let me reiterate that our …

India Vaccinating Population Size of Norway Everyday; Drive a Marathon, Not Sprint: Govt
3 years, 5 months ago

India Vaccinating Population Size of Norway Everyday; Drive a Marathon, Not Sprint: Govt

News 18  

India is vaccinating on an average 50 lakh individuals daily since June 21, equivalent to inoculating the entire population of Norway every day, the Centre said on Friday and asserted that the process is like a marathon and not a 100-metre race. Addressing a press briefing, Lav Agarwal, Joint Secretary, health ministry, said till date, 34 crore people–equivalent to the …

Jaishankar, African Union flag ‘vaccine equity’
3 years, 5 months ago

Jaishankar, African Union flag ‘vaccine equity’

The Hindu  

International cooperation is the way forward to deal with vaccine requirements to counter the threat of COVID-19 pandemic, External Affairs Minister S Jaishankar said on Tuesday during the G20 Foreign Ministers meeting at Matera in Italy. The comment came on a day when the African Union said Covishield of Serum Institute of India has been the “backbone” of the vaccination …

Discover Related